Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
J. Bispham1, M. Grady2, J. Liu3, H. Nguyen3, K. Chapman3, S. Sandip Shah4, H. Gonzalez Piñero5, E. Holt6
Background and Aims: Continuous glucose monitoring (CGM) offers a deeper understanding of multiple factors affecting glucose management. We sought to quantify factors patients thought impacted sensor performance or decision making.
Methods: An online survey was reviewed by an Institutional Review Board and offered to people ages 18+ with type 1 (T1D) or type 2 diabetes (T2D) who were former or current CGM users within the T1D Exchange community. Analyses were conducted by T1D Exchange.
Results: 563 current and 42 former CGM users (504 T1D, 101 T2D) responded. 67% current users used Dexcom, 19% Medtronic and 13% Abbott Libre systems. 49% (n = 295/605) had previously temporarily stopped using CGM, of whom 59% (173/295) stopped for ≥1 month. Despite 90% stating majority of sensors were accurate, 42% (251/605) thought accuracy varied from sensor to sensor. 15% stated ≤6/10 sensors could be described as accurate (88/605). 26% (158/605) agreed poor sensors often affected their confidence dosing insulin or ability to make diabetes management decisions (25%, 149/605). 35% (211/605) were concerned about the effect of over‐the‐counter or prescription medications on sensor accuracy, with 43% (259/605) or 32% (195/605) suspecting either pain relief or cold/flu remedies affected sensor accuracy, respectively.
Full study abstract listed under number EP158 / #83 at this link
This site uses Akismet to reduce spam. Learn how your comment data is processed.